Swiss fertility heavyweight bets on stem-cell-derived egg maturation – and on ovarian biology as a market worth owning.

XellSmart’s off-the-shelf XS411 lifted motor scores in nine patients, and its 30-person Phase II trial has finished enrolling ...

Rapalogix reports firmer, more elastic skin in a double-blind study of its longevity serum, and the details are worth a close ...

Cognito Therapeutics and the state’s Life Science Hub are building a statewide platform around its Alzheimer’s therapy, ...

Sironax is about halfway to its enrollment target in a Phase 2 trial of an oral NAMPT activator for adults with obesity.

Arrowhead says its RNAi drug crossed the blood-brain barrier in healthy volunteers and sharply lowered tau, a protein tied to Alzheimer’s.

GlobalData says more adults with type 2 diabetes in England hit blood sugar and weight targets on tirzepatide than on ...

Indianapolis-based Carnyx says its oral drug boosted NREM sleep in aged animals, and it has hired Chris Brearley as chief ...

Berlin keynote details Eos SENOLYTIX's pre-clinical results with mitochondrial-targeted geropeptide on healthspan and lifespan.

INmune Bio is pairing a quantum machine with AI to find diseases beyond Alzheimer’s that its drug candidate might help.

KAUST and Oxford researchers used a transistor-based sensor to read three forms of alpha-synuclein, reaching 90.9% accuracy ...

Cognition Therapeutics wins a US patent on a new crystal form of zervimesine and has an FDA meeting on its Lewy body trial ...